Science Explorer Back to mapMap
Discussion
Company · Vienna · Austria

Octapharma (Austria)

Research works
113
▲ 97% vs 2018-21
Citations
2.7k
23.8 per fractional work
Top-10% rate
11.6%
all institutions 10.0%
Open access
26%
world 40%
International
39%
world 18%

Not ranked overall: Octapharma (Austria) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Octapharma (Austria) work in?

In all years, 57% of research at Octapharma (Austria) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (18%), Chemistry (7%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 65 fractional works · 57.2% of its workMedicine: 62 fractional works · 55.2% of its workHematology: 29 fractional works · 25.4% of its workBiochemistry: 7 fractional works · 6.0% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 3.5% of its workPulmonary and Respiratory Medicine: 3 fractional works · 3.1% of its workCritical Care and Intensive Care Medicine: 3 fractional works · 2.6% of its workGenetics: 3 fractional works · 2.3% of its workInfectious Diseases: 2 fractional works · 1.7% of its workSurgery: 2 fractional works · 1.7% of its workEpidemiology: 2 fractional works · 1.6% of its workPhysiology: 2 fractional works · 1.4% of its workNeurology: 1 fractional works · 1.1% of its workHepatology: 1 fractional works · 0.7% of its workRheumatology: 1 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workInternal Medicine: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workOncology: 0 fractional works · 0.2% of its workRehabilitation: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.8% of its workHealth Professions: 1 fractional works · 0.8% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workGeneral Health Professions: 0 fractional works · 0.4% of its workNursing: 1 fractional works · 0.6% of its workNutrition and Dietetics: 1 fractional works · 0.6% of its workVeterinary: 1 fractional works · 0.5% of its workSmall Animals: 1 fractional works · 0.5% of its workLife Sciences: 28 fractional works · 24.7% of its workBiochemistry, Genetics and Molecular Biology: 20 fractional works · 18.0% of its workMolecular Biology: 16 fractional works · 13.9% of its workCell Biology: 2 fractional works · 1.8% of its workGenetics: 1 fractional works · 1.0% of its workPhysiology: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 5 fractional works · 4.5% of its workImmunology: 5 fractional works · 4.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 0.6% of its workFood Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 15 fractional works · 13.7% of its workChemistry: 8 fractional works · 7.4% of its workSpectroscopy: 6 fractional works · 5.4% of its workOrganic Chemistry: 1 fractional works · 1.0% of its workAnalytical Chemistry: 1 fractional works · 1.0% of its workEngineering: 4 fractional works · 3.8% of its workBiomedical Engineering: 4 fractional works · 3.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workEnvironmental Science: 1 fractional works · 1.2% of its workEcology: 1 fractional works · 0.5% of its workNature and Landscape Conservation: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 1.2% of its workSurfaces, Coatings and Films: 1 fractional works · 0.5% of its workMaterials Chemistry: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.1% of its workSocial Sciences: 5 fractional works · 4.5% of its workBusiness, Management and Accounting: 5 fractional works · 4.5% of its workManagement of Technology and Innovation: 5 fractional works · 4.5% of its workALL ITS WORKOctapharma(Austria)113fractional works, all years
Life Sciences25%Physical Sciences14%Health Sciences57%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine6255.2%
    2. Health Professions10.8%
    3. Nursing10.6%
    4. Veterinary10.5%
    1. Biochemistry, Genetics and Molecular Biology2018.0%
    2. Immunology and Microbiology54.5%
    3. Neuroscience10.8%
    4. Pharmacology, Toxicology and Pharmaceutics10.7%
    5. Agricultural and Biological Sciences10.6%
    1. Chemistry87.4%
    2. Engineering43.8%
    3. Environmental Science11.2%
    4. Materials Science11.2%
    5. Physics and Astronomy00.1%
    6. Computer Science00.1%
    1. Business, Management and Accounting54.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.87× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 1.92× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 2.61× its world share, 0 worksPharmacology, Toxico…Chemistry: 4.11× its world share, 1 worksChemistryEngineering: 0.20× its world share, 0 worksEngineeringEnvironmental Science: 0.93× its world share, 1 worksEnvironmental ScienceHealth Professions: 0.08× its world share, 0 worksHealth ProfessionsMedicine: 3.20× its world share, 11 worksMedicineNursing: 2.16× its world share, 0 worksNursingVeterinary: 13.55× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 2.67× its world share, 2 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 13.6×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Veterinary13.55×0 works
  2. Chemistry4.11×1 works
  3. Medicine3.20×11 works
  4. Business, Management and Accounting2.67×2 works
  5. Pharmacology, Toxicology and Pharmaceutics2.61×0 works
  6. Nursing2.16×0 works
  7. Immunology and Microbiology1.92×0 works
  8. Biochemistry, Genetics and Molecular Biology1.87×2 works
  9. Environmental Science0.93×1 works
  10. Engineering0.20×0 works
  11. Health Professions0.08×0 works

Who are the top researchers at Octapharma (Austria)?

Ranked on the quality score, Martina Jansen, Andrea Buchacher and Elisabeth Clodi lead among researchers whose main affiliation is Octapharma (Austria).

  1. 1 Martina Jansen Austria · #1,175,260 worldwide 587 citations · 35 works
  2. 2 Andrea Buchacher Austria · #1,408,000 worldwide 3.7k citations · 51 works
  3. 3 Elisabeth Clodi Austria · #1,434,621 worldwide 326 citations · 16 works
  4. 4 Dj. Josić Austria · #3,515,695 worldwide 618 citations · 24 works
  5. 5 Stefan Wietek Austria · #3,704,652 worldwide 286 citations · 22 works
  6. 6 Andrea Heger Austria · #4,319,642 worldwide 520 citations · 34 works
  7. 7 Andrea Neisser‐Svae Austria · #4,357,170 worldwide 268 citations · 16 works
  8. 8 Katharina Pock Austria · #4,470,044 worldwide 495 citations · 32 works
  9. 9 Tor‐Einar Svae Austria · #4,599,507 worldwide 344 citations · 23 works
  10. 10 Marnix R. Jansen Austria · #4,723,108 worldwide 230 citations · 36 works
All ranked researchers at Octapharma (Austria)

What are the most cited papers from Octapharma (Austria)?

The most cited paper from Octapharma (Austria) is "Complement factor H binds malondialdehyde epitopes and protects from oxidative stress" (David Weismann, Karsten Hartvigsen, Nadine Lauer et al., 2011), with 537 citations. Next come "Trial of Intravenous Immune Globulin in Dermatomyositis" (225) and "Antithrombin" (210).

Most cited papers
#PaperReleasedCitations
1 Complement factor H binds malondialdehyde epitopes and protects from oxidative stress David Weismann, Karsten Hartvigsen, Nadine Lauer et al. · Nature Open access Oct 2011 537
2 Trial of Intravenous Immune Globulin in Dermatomyositis Rohit Aggarwal et al. · New England Journal of Medicine Open access 5 Oct 2022 225
3 Antithrombin Juergen Roemisch, Elaine Gray, Johannes N. Hoffmann et al. · Blood Coagulation & Fibrinolysis Dec 2002 210
4 Monoliths as stationary phases for separation of proteins and polynucleotides and enzymatic conversion Djuro Josić, Andrea Buchacher, Alois Jungbauer · Journal of Chromatography B Biomedical Sciences and Applications Mar 2001 203
5 Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial Richard C. Dodel et al. · The Lancet Neurology Open access 30 Jan 2013 186
All 60 most cited papers, with filters and sorting

Which keywords describe research at Octapharma (Austria)?

By fractional works in all years, weighted toward what it does more of than the world: Hemostasis, Monoclonal Antibodies, Anemia, Blood Transfusion, Therapeutic Antibodies, Inflammation, Prophylaxis and Gene Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation14▲ 5.1×14 topics
  2. Hemostasis14▲ 80×3 topics
  3. Anemia12▲ 90×3 topics
  4. Monoclonal Antibodies12▲ 73×3 topics
  5. Blood Transfusion12▲ 192×2 topics
  6. Therapeutic Antibodies12▲ 79×2 topics
  7. Prophylaxis10▲ 64×2 topics
  8. Gene Therapy10▲ 34×4 topics
  9. Protein Aggregation10▲ 111×2 topics
  10. Factor VIII10▲ 498×1 topic
  11. Hemophilia10▲ 498×1 topic
  12. Recombinant Factor VIIa10▲ 205×2 topics
  13. Hemorrhage10▲ 117×2 topics
  14. Thrombosis9▲ 37×5 topics
  15. Biopharmaceuticals9▲ 113×2 topics
  16. Immunogenicity9▲ 151×2 topics
  17. Recombinant Proteins8▲ 141×1 topic
  18. Stability8▲ 39×1 topic
  19. Critical Care7▲ 28×3 topics
  20. Immune Thrombocytopenic Purpura7▲ 159×1 topic
  21. Platelets7▲ 98×1 topic
  22. Cardiac Surgery7▲ 75×1 topic
  23. Tranexamic Acid7▲ 281×1 topic
  24. Risk Factors6▲ 4.6×2 topics
  25. Blood Donation5▲ 300×1 topic
  26. Supply Chain Management5▲ 8.7×1 topic
  27. Antithrombotic Therapy5▲ 39×2 topics
  28. Glycosylation4▲ 18×3 topics
  29. Alloimmunization4▲ 101×1 topic
  30. Blood Groups4▲ 101×1 topic
  31. Pregnancy4▲ 17×2 topics
  32. Protease-Activated Receptors4▲ 101×1 topic
  33. Thrombin4▲ 101×1 topic
  34. Liquid Chromatography4▲ 21×2 topics
  35. Mass Spectrometry4▲ 15×4 topics
  36. Sepsis3▲ 18×2 topics
  37. Chiral Separation3▲ 23×1 topic
  38. Gas Chromatography3▲ 23×1 topic
  39. Coagulopathy3▲ 33×2 topics
  40. Resuscitation3▲ 21×2 topics

Which research topics does Octapharma (Austria) publish most on?

By volume in 2022-now: Blood transfusion and management, Hemophilia Treatment and Research, Blood donation and transfusion practices and Trauma, Hemostasis, Coagulopathy, Resuscitation.

  1. 1 Blood transfusion and management Biochemistry 2 works
  2. 2 Hemophilia Treatment and Research Hematology 2 works
  3. 3 Blood donation and transfusion practices Management of Technology and Innovation 2 works
  4. 4 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 1 works
  5. 5 Protein purification and stability Molecular Biology 1 works
  6. 6 Platelet Disorders and Treatments Hematology 1 works
  7. 7 Inflammatory Myopathies and Dermatomyositis Epidemiology 1 works
  8. 8 Analytical Chemistry and Chromatography Spectroscopy 0 works
  9. 9 Organ Donation and Transplantation Public Health, Environmental and Occupational Health 0 works
  10. 10 Reproductive biology and impacts on aquatic species Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available25.6%not open74.4%

World: 40% of research is openly available.

with international co-authors39.3%domestic only60.7%

World: 18% is written across borders.

How has Octapharma (Austria)'s research output changed?

Output in 2022-2025 was 97% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Octapharma (Austria) as a percentage of every work published that year, 0.000039% in 2024.

still counting0.00020%0.00040%0.00060%Octapharma (Austria)0.00013% in 20251990200020102020

Fractional works of Octapharma (Austria) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Vienna

All research institutions in Vienna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Octapharma (Austria). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.